Delivery Order SPE2DB22D2007-SPE2DB25FJ1ZP
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,933.57 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine (syringes/milliliter) under a firm fixed price arrangement. The award was made on July 10, 2025, with an ultimate completion date of July 11, 2025, and performance is to be completed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $22,886.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply. This firm fixed price contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,027.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine product, with an ultimate completion date of September 15, 2025. The delivery order, issued on September 12, 2025, is a non-set-aside award executed under a competitive procurement process. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its primary location. This delivery order...
- The Defense Logistics Agency awarded a $1,040.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for ENGERIX-B 20 MCG/ML vaccine supply. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,940.38 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply. This competitively awarded, firm fixed-price delivery order was issued on October 31, 2025, with an ultimate completion date of November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's established capability...
- The Defense Logistics Agency awarded a delivery order valued at $2,061.12 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price contract, which is not set-aside, is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,607.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, with performance in Conshohocken, Pennsylvania and completion targeted for June 17, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,762.25 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania. This non-competitive delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, under firm fixed-price terms. The award represents a small-value transaction typical of routine pharmaceutical replenishment activities within the federal medical supply chain....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ1ZPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine on June 3, 2025, with a ceiling value of $3,753.42. This is a firm fixed price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies the Defense Logistics Agency and broader military healthcare systems with a comprehensive range of pharmaceutical products and medical supplies. This particular delivery order for ENGERIX-B vaccine—a hepatitis B immunization—supports military and veteran healthcare programs as part of the company's extensive portfolio of vaccinations, specialty medications, generic drugs, and medical supplies across multiple therapeutic domains. The competitively awarded contract reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 6/3/25 |